August 16, 2026 03:12 am (IST)
Follow us:
GlaxoSmithKline records 11% growth for Q2
New Delhi, Nov 5 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the second quarter ended September 30, 2014.
The company's net sales were reported at Rs 1075 crores, which recorded a growth of 11% over 2013 with PAT at Rs. 160 crores growing by 9% for the same period and PBT at Rs 245 crores growing by 10%.
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are delighted to have delivered consistent growth as the category leader. The consumer sentiments are showing early signs of recovery and our brands are well poised to help consumers do more, feel better and live longer. Our relentless focus on science, innovation and customer, remains our key differentiator and helps us to stay ahead in the category."
"We continue to improve consumer’s experience with new products like the re-launched Horlicks with proven health benefits, ‘instantization’ and new positioning, highlighting its daily nutritional relevance. We also remain focused on our access strategy to ensure that our products are within the easy reach of our large consumer base,” Ahmed said.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Reliance Industries, Rolls-Royce join hands to explore indigenous engine for India’s AMCA fighter
Sat, Aug 15 2026
BSNL’s Independence Day gift: Re 1 Recharge, 412-Day Plan and 500 Free TV Channels. Check now
Sat, Aug 15 2026
Emami’s big snack bet: ₹750 crore investment, new WeMe brand targets ₹1,000 crore in 3-5 years
Sat, Aug 15 2026
HCG Q1 results: Cancer care major posts 190% jump in adjusted profit, revenue rises 13%
Fri, Aug 14 2026
Big relief for Zee Entertainment: SAT allows warrants issue, dividend access despite SEBI ban
Fri, Aug 14 2026
Olectra Greentech Q1 shocker: Revenue soars 66%, profit barely moves; shares crash 4%
Fri, Aug 14 2026
Red Friday on Dalal Street: Sensex plunges 300 points, Nifty slides amid geopolitical tensions
Fri, Aug 14 2026
Tata Motors shares jump 6% after Q1 profit soars 83% to ₹2,560 crore
Thu, Aug 13 2026